Stricter Laws Reduce Prescription Drug Overdose Deaths in Florida

Published Online: Friday, July 11, 2014
Follow Pharmacy_Times:
Deaths caused by prescription drug overdoses have dramatically decreased in Florida after the state tightened prescribing laws and implemented other enforcement actions to reduce prescribing for opioid painkillers and other controlled substances, according to a report in the July 1, 2014, issue of the Centers for Disease Control and Prevention’s Morbidity & Mortality Weekly Report.

From 2003 to 2009, the number of deaths caused by drug overdoses increased by 61% in Florida, with particularly large increases seen in the number of deaths caused by oxycodone and alprazolam. To reduce the number of deaths, the state enacted various laws and actions to curb inappropriate prescribing.

Pain clinics using controlled substances were required to register with the state and to comply with additional regulations implemented in 2010. In 2011, statewide raids were conducted, resulting in arrests, seizures, and the closures of several pain clinics. Later that year, the state legislature prohibited physician dispensing of schedule II or III drugs from their offices, and pharmacies were required to report dispensing of the medications to the new prescription drug monitoring program. In addition, regulation of wholesale drug distributors was expanded.

These efforts resulted in a 16.7% decrease in the number of overall drug overdose deaths during 2010 to 2012. Death rates for prescription drug overdoses decreased by 23.2%. Deaths caused by oxycodone decreased by 52.1%. The temporal associations between the enforcement actions and declines in overdose deaths suggest that the initiatives played a significant role in reducing overdoses in the state.

Related Articles
Julie Johnson, PharmD, dean of the University of Florida’s College of Pharmacy, has won the 2015 Distinguished Scientist Award from the Southeastern Universities Research Association.
The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled “Stakeholders’ Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances.”
R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about how Medicare Part B, C, and D-compliant practices change overall pharmacy practice.
R. Jeffrey Hedges, president and CEO of RJ Hedges and Associates, talks about how pharmacists can ensure they are compliant with Medicare Part B, C, and D standards.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times